Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;38(4):333-342.
doi: 10.1615/CritRevImmunol.2018026483.

How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses

Jillian P Rhoads  1 , Amy S Major  2
Affiliations
Review

How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses

Jillian P Rhoads et al. Crit Rev Immunol. 2018.

Abstract

Cardiovascular disease (CVD) is the number one cause of death in the United States and worldwide. The most common cause of cardiovascular disease is atherosclerosis, or formation of fatty plaques in the arteries. Low-density lipoprotein (LDL), termed "bad cholesterol", is a large molecule comprised of many proteins as well as lipids including cholesterol, phospholipids, and triglycerides. Circulating levels of LDL are directly associated with atherosclerosis disease severity. Once thought to simply be caused by passive retention of LDL in the vasculature, atherosclerosis studies over the past 40-50 years have uncovered a much more complex mechanism. It has now become well established that within the vasculature, LDL can undergo many different types of oxidative modifications such as esterification and lipid peroxidation. The resulting oxidized LDL (oxLDL) has been found to have antigenic potential and contribute heavily to atherosclerosis associated inflammation, activating both innate and adaptive immunity. This review discusses the many proposed mechanisms by which oxidized LDL modulates inflammatory responses and how this might modulate atherosclerosis.

PubMed Disclaimer

Figures

FIG. 1:
FIG. 1:
OxLDL modulates innate and adaptive immunity. OxLDL activates macrophages and dendritic cells via uptake by scavenger receptors and TLRs, generates specific CD4+ and CD8+ T-cell responses, and stimulates systemic oxLDL-antibody production.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, De Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, MacKey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB. Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447–54. - PubMed
    1. Sandison AT. Degenerative vascular disease in the Egyptian mummy. Med Hist. 1962;6:77–81. - PMC - PubMed
    1. Zimmerman M The paleophysiology of the cardiovascular system. Texas Heart Inst J. 1993;20:252–57. - PMC - PubMed
    1. Rokitansky K A manual of pathological anatomy. Philadelphia: Blanchard & Lee; 1855.
    1. Virchow R Cellular pathology as based upon physiological and pathological histology. Philadelphia: J B Lippincott; 1863. - PubMed

Publication types

Substances